NMNAT1 inhibits axon degeneration via blockade of SARM1-mediated NAD+depletion

eLife

Volumn 5, Issue OCTOBER2016, 2016, Pages

  Sasaki, Yo ^a   Nakagawa, Takashi ^b   Mao, Xianrong ^a   DiAntonio, Aaron ^a   Milbrandt, Jeffrey ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TOYAMA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; COMPLEMENTARY DNA; LENTIVIRUS VECTOR; NICOTINAMIDE ADENINE DINUCLEOTIDE; NICOTINAMIDE NUCLEOTIDE; NICOTINAMIDE NUCLEOTIDE ADENYLYLTRANSFERASE; NICOTINAMIDE RIBOSIDE; SELECTIVE ANDROGEN RECEPTOR MODULATOR; ARMADILLO DOMAIN PROTEIN; CYTOSKELETON PROTEIN; NMNAT1 PROTEIN, MOUSE; SARM1 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BIOSYNTHESIS; CONTROLLED STUDY; FETUS; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MASS SPECTROMETRY; METABOLIC FLUX ANALYSIS; METABOLITE; MOUSE; MUTANT; NERVE FIBER DEGENERATION; NONHUMAN; SPINAL GANGLION; STEADY STATE; ANIMAL; AXON; GENETICS; METABOLISM; NERVE DEGENERATION; PATHOLOGY;

ANIMALS; ARMADILLO DOMAIN PROTEINS; AXONS; CYTOSKELETAL PROTEINS; GANGLIA, SPINAL; MICE; NAD; NERVE DEGENERATION; NICOTINAMIDE-NUCLEOTIDE ADENYLYLTRANSFERASE;

EID: 84991628947     PISSN: None     EISSN: 2050084X     Source Type: Journal    
DOI: 10.7554/eLife.19749     Document Type: Article

References (25)

1. Araki T, Sasaki Y, Milbrandt J. 2004. Increased nuclear NAD biosynthesis and SIRT1 activation prevent axonal degeneration. Science 305:1010-1013. doi:10.1126/science.1098014
2. Babetto E, Beirowski B, Janeckova L, Brown R, Gilley J, Thomson D, Ribchester RR, Coleman MP. 2010. Targeting NMNAT1 to axons and synapses transforms its neuroprotective potency in vivo. Journal of Neuroscience 30:13291-13304. doi:10.1523/JNEUROSCI.1189-10.2010
3. Coleman M. 2005. Axon degeneration mechanisms: commonality amid diversity. Nature Reviews Neuroscience 6:889-898. doi:10.1038/nrn1788
4. Conforti L, Gilley J, Coleman MP. 2014. Wallerian degeneration: an emerging axon death pathway linking injury and disease. Nature Reviews Neuroscience 15:394-409. doi:10.1038/nrn3680
5. Di Stefano M, Nascimento-Ferreira I, Orsomando G, Mori V, Gilley J, Brown R, Janeckova L, Vargas ME, Worrell LA, Loreto A, Tickle J, Patrick J, Webster JR, Marangoni M, Carpi FM, Pucciarelli S, Rossi F, Meng W, Sagasti A, Ribchester RR, et al. 2015. A rise in NAD precursor nicotinamide mononucleotide (NMN) after injury promotes axon degeneration. Cell Death and Differentiation 22:731-742. doi:10.1038/cdd.2014.164
6. Elliott GC, Rechsteiner MC. 1982. Evidence for a physiologically active nicotinamide phosphoribosyltransferase in cultured human fibroblasts. Biochemical and Biophysical Research Communications 104:996-1002. doi:10.1016/0006-291X(82)91348-1
7. Gerdts J, Sasaki Y, Vohra B, Marasa J, Milbrandt J. 2011. Image-based screening identifies novel roles for IkappaB kinase and glycogen synthase kinase 3 in axonal degeneration. Journal of Biological Chemistry 286: 28011-28018. doi:10.1074/jbc.M111.250472
8. Gerdts J, Summers DW, Sasaki Y, DiAntonio A, Milbrandt J. 2013. Sarm1-mediated axon degeneration requires both SAM and TIR interactions. Journal of Neuroscience 33:13569-13580. doi:10.1523/JNEUROSCI.1197-13.2013
9. Gerdts J, Brace EJ, Sasaki Y, DiAntonio A, Milbrandt J. 2015. SARM1 activation triggers axon degeneration locally via NAD+ destruction. Science 348:453-457. doi:10.1126/science.1258366
10. Gerdts J, Summers DW, Milbrandt J, DiAntonio A. 2016. Axon Self-Destruction: New Links among SARM1, MAPKs, and NAD+ Metabolism. Neuron 89:449-460. doi:10.1016/j.neuron.2015.12.023
11. Gilley J, Coleman MP. 2010. Endogenous Nmnat2 is an essential survival factor for maintenance of healthy axons. PLoS Biology 8:e1000300. doi:10.1371/journal.pbio.1000300
12. Gilley J, Orsomando G, Nascimento-Ferreira I, Coleman MP. 2015. Absence of SARM1 rescues development and survival of NMNAT2-deficient axons. Cell Reports 10:1974-1981. doi:10.1016/j.celrep.2015.02.060
13. 2H/¹H exchange at the redox site of NAD+/NADH. Journal of Nutritional Science and Vitaminology 60:17-21. doi:10.3177/jnsv.60.17
14. Hikosaka K, Ikutani M, Shito M, Kazuma K, Gulshan M, Nagai Y, Takatsu K, Konno K, Tobe K, Kanno H, Nakagawa T. 2014. Deficiency of nicotinamide mononucleotide adenylyltransferase 3 (nmnat3) causes hemolytic anemia by altering the glycolytic flow in mature erythrocytes. Journal of Biological Chemistry 289: 14796-14811. doi:10.1074/jbc.M114.554378
15. Lois C, Hong EJ, Pease S, Brown EJ, Baltimore D. 2002. Germline transmission and tissue-specific expression of transgenes delivered by lentiviral vectors. Science 295:868-872. doi:10.1126/science.1067081
16. Mack TG, Reiner M, Beirowski B, Mi W, Emanuelli M, Wagner D, Thomson D, Gillingwater T, Court F, Conforti L, Fernando FS, Tarlton A, Andressen C, Addicks K, Magni G, Ribchester RR, Perry VH, Coleman MP. 2001. Wallerian degeneration of injured axons and synapses is delayed by a Ube4b/Nmnat chimeric gene. Nature Neuroscience 4:1199-1206. doi:10.1038/nn770
17. Osterloh JM, Yang J, Rooney TM, Fox AN, Adalbert R, Powell EH, Sheehan AE, Avery MA, Hackett R, Logan MA, MacDonald JM, Ziegenfuss JS, Milde S, Hou YJ, Nathan C, Ding A, Brown RH, Conforti L, Coleman M, Tessier-Lavigne M, et al. 2012. dSarm/Sarm1 is required for activation of an injury-induced axon death pathway. Science 337:481-484. doi:10.1126/science.1223899
18. Revollo JR, Grimm AA, Imai S. 2004. The NAD biosynthesis pathway mediated by nicotinamide phosphoribosyltransferase regulates Sir2 activity in mammalian cells. Journal of Biological Chemistry 279: 50754-50763. doi:10.1074/jbc.M408388200
19. Sasaki Y, Araki T, Milbrandt J. 2006. Stimulation of nicotinamide adenine dinucleotide biosynthetic pathways delays axonal degeneration after axotomy. Journal of Neuroscience 26:8484-8491. doi:10.1523/JNEUROSCI.2320-06.2006
20. Sasaki Y, Vohra BPS, Baloh RH, Milbrandt J. 2009a. Transgenic mice expressing the Nmnat1 protein manifest robust delay in axonal degeneration in vivo. Journal of Neuroscience 29:6526-6534. doi:10.1523/JNEUROSCI.1429-09.2009
21. Sasaki Y, Vohra BPS, Lund FE, Milbrandt J. 2009b. Nicotinamide mononucleotide adenylyl transferase-mediated axonal protection requires enzymatic activity but not increased levels of neuronal nicotinamide adenine dinucleotide. Journal of Neuroscience 29:5525-5535. doi:10.1523/JNEUROSCI.5469-08.2009
22. Sasaki Y, Milbrandt J. 2010. Axonal degeneration is blocked by nicotinamide mononucleotide adenylyltransferase (Nmnat) protein transduction into transected axons. Journal of Biological Chemistry 285: 41211-41215. doi:10.1074/jbc.C110.193904
23. Szretter KJ, Samuel MA, Gilfillan S, Fuchs A, Colonna M, Diamond MS. 2009. The immune adaptor molecule SARM modulates tumor necrosis factor alpha production and microglia activation in the brainstem and restricts West Nile Virus pathogenesis. Journal of Virology 83:9329-9338. doi:10.1128/JVI.00836-09
24. Wang J, Zhai Q, Chen Y, Lin E, Gu W, McBurney MW, He Z. 2005. A local mechanism mediates NAD-dependent protection of axon degeneration. The Journal of Cell Biology 170:349-355. doi:10.1083/jcb.200504028
25. Wang JT, Medress ZA, Barres BA. 2012. Axon degeneration: molecular mechanisms of a self-destruction pathway. The Journal of Cell Biology 196:7-18. doi:10.1083/jcb.201108111